2.600
−3,70%
2026-10-19
Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +95.5% | -270.8% | 2 / 3 | -51.3% | +0.25 pp | +1.15 pp | +1.7% | 0.05 | 15.40 | 118 | −51,3% | −0,1 | +95,3% | 15.40 | 23.00 | −33,0% |
| Pts | 12 | 0 | 8 | 0 | 8 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 2.600 (close price on 2026-10-19)EPS (TTM): 168,8
Financial charts
1.Revenue & growth
VND bn118Q2/26
1.Revenue & growth
VND bn118Q2/26
2.Profit & growth
VND bn-0,15Q2/26
3.Profit mix (Penman)
VND bn6,38Q2/26
4.Margins & cost structure
%3.5%Q2/26
5.Returns & cash cycle
% · days1.4%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn310Q2/26
8.Funding & debt health
VND bn · times310Q2/26
9.Revenue backlog
VND bn9,74Q2/26
10.Valuation
times · %15,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-6Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-454%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26